After analyzing extensive variety of tumor patients’ survival data from several large databases, we confirmed low expression level of TOX is significantly correlated with poor prognosis in multiple cancers types comprising breast cancer, brain low grade glioma, and particularly LUAD (Figure 2A‐I). The gene discussed is TOX; the disease is breast cancer.